Melanoma Research

Putative genomic characteristics of BRAF V600K versus V600E cutaneous melanoma
pp. 527-535(9)
Authors: Li, Yuanyuan; Umbach, David M.; Li, Leping

Metformin: oxidative and proliferative parameters in-vitro and in-vivo models of murine melanoma
pp. 536-544(9)
Authors: de Souza Neto, Fernando P.; Bernardes, Sara S.; Marinello, Poliana C.; Melo, Gabriella P.; Luiz, Rodrigo C.; Cecchini, Rubens; Cecchini, Alessandra L.

Resistance mechanisms to genetic suppression of mutant NRAS in melanoma
pp. 545-557(13)
Authors: Robinson, James P.; Rebecca, Vito W.; Kircher, David A.; Silvis, Mark R.; Smalley, Inna; Gibney, Geoffrey T.; Lastwika, Kristin J.; Chen, Guo; Davies, Michael A.; Grossman, Douglas; Smalley, Keiran S.M.; Holmen, Sheri L.; VanBrocklin, Matthew W.

A prospective multicenter cohort study of cutaneous melanoma: clinical staging and potential associations with HIF-1α and VEGF expressions
pp. 558-564(7)
Authors: Martínez-García, Miguel Ángel; Riveiro-Falkenbach, Erica; Rodríguez-Peralto, José L.; Nagore, Eduardo; Martorell-Calatayud, Antonio; Campos-Rodríguez, Francisco; Farré, Ramón; Hernández Blasco, Luis; Bañuls Roca, Jose; Chiner Vives, Eusebi; Sánchez-de-la-Torre, Alicia; Abad Capa, Jorge; Montserrat, Josep Maria; Almendros, Isaac; Pérez-Gil, Amalia; Cabriada Nuño, Valentin; Cano-Pumarega, Irene; Corral Peñafiel, Jaime; Diaz Cambriles, Trinidad; Mediano, Olga; Dalmau Arias, Joan; Gozal, David

PD-1/PD-L1 and VEGF-A/VEGF-C expression in lymph node microenvironment and association with melanoma metastasis and survival
pp. 565-572(8)
Authors: Alessi, Cristina; Scapulatempo Neto, Cristovam; Viana, Cristiano R.; Vazquez, Vinicius de Lima

Single-stage excision and sentinel lymph node biopsy in cutaneous melanoma in selected patients: a retrospective case–control study
pp. 573-579(7)
Authors: Giudice, Giuseppe; Robusto, Fabio; Vestita, Michelangelo; Annoscia, Paolo; Elia, Rossella; Nacchiero, Eleonora

Bevacizumab as an effective treatment for radiation necrosis after radiotherapy for melanoma brain metastases
pp. 580-584(5)
Authors: Glitza, Isabella C.; Guha-Thakurta, Nandita; D’Souza, Neil M.; Amaria, Rodabe N.; McGovern, Susan L.; Rao, Ganesh; Li, Jing

Vemurafenib treatment for patients with locally advanced, unresectable stage IIIC or metastatic melanoma and activating exon 15 BRAF mutations other than V600E
pp. 585-590(6)
Authors: Hallmeyer, Sigrun; Gonzalez, Rene; Lawson, David H.; Cranmer, Lee D.; Linette, Gerald P.; Puzanov, Igor; Taback, Bret; Cowey, C. Lance; Ribas, Antoni; Daniels, Gregory A.; Moore, Timothy; Gibney, Geoffrey T.; Tawbi, Hussein; Whitman, Eric; Lee, Geraldine; Mun, Yong; Liu, Shiyao; Hamid, Omid

Cisplatin, dacarbazine and vinblastine as first line chemotherapy for liver metastatic uveal melanoma in the era of immunotherapy: a single institution phase II study
pp. 591-595(5)
Authors: Schinzari, Giovanni; Rossi, Ernesto; Cassano, Alessandra; Dadduzio, Vincenzo; Quirino, Michela; Pagliara, Monica; Blasi, Maria A.; Barone, Carlo

Lymphocyte-to-monocyte ratio is associated with survival in pembrolizumab-treated metastatic melanoma patients
pp. 596-600(5)
Authors: Failing, Jarrett J.; Yan, Yiyi; Porrata, Luis F.; Markovic, Svetomir N.

Primary malignant melanoma arising in an ovarian cystic teratoma
pp. 601-606(6)
Authors: Shen, Xuejie; Fan, Yang; Cao, Shui

Economic burden of advanced melanoma in France, Germany and the UK: a retrospective observational study (Melanoma Burden-of-Illness Study)
pp. 607-618(12)
Authors: Grange, Florent; Mohr, Peter; Harries, Mark; Ehness, Rainer; Benjamin, Laure; Siakpere, Obukohwo; Barth, Janina; Stapelkamp, Ceilidh; Pfersch, Sylvie; McLeod, Lori D.; Kaye, James A.; Wolowacz, Sorrel; Kontoudis, Ilias

Impact of socioeconomic status and district of residence on cutaneous malignant melanoma prognosis: a survival study on incident cases between 1991 and 2011 in the province of Ferrara, northern Italy
pp. 619-624(6)
Authors: Borghi, Alessandro; Corazza, Monica; Virgili, Annarosa; Lambertini, Anna G.; Caranci, Nicola; Pacelli, Barbara; Carcoforo, Paolo; Ferretti, Stefano

The role of depression and personality traits in patients with melanoma: a South-European study
pp. 625-631(7)
Authors: Gogas, Helen J.; Karalexi, Maria A.; Dessypris, Nick; Antoniadis, Antonios G.; Papadopoulos, Fotis; Petridou, Eleni T.

Acute motor and sensory axonal neuropathy related to treatment with MEK inhibitors in a patient with advanced melanoma
pp. 632-634(3)
Authors: Taha, Tarek; Tzuk-Shina, Tzahala; Forschner, Itay; Bar-Sela, Gil

A case of pure red cell aplasia during nivolumab therapy for cardiac metastatic melanoma
pp. 635-637(3)
Authors: Yuki, Akihiko; Takenouchi, Tatsuya; Takatsuka, Sumiko; Ishiguro, Takuro

Multiple primary melanoma: a single centre retrospective review
pp. 638-640(3)
Authors: Menzies, Stephanie; Barry, Rupert; Ormond, Patrick

Intracorneal pustular drug eruption, a novel cutaneous adverse event in anti-programmed cell death-1 patients that highlights the effect of anti-programmed cell death-1 in neutrophils
pp. 641-644(4)
Authors: Zhao, Cathy Yunjia; Consuegra, Germana; Chou, Shaun; Fernández-Peñas, Pablo

A family with two cases of melanocytic tumors and fragile X syndrome
pp. 645-648(4)
Authors: Lesage, Candice; Coupier, Isabelle; Guillot, Bernard

Transient pituitary ACTH-dependent Cushing syndrome caused by an immune checkpoint inhibitor combination
pp. 649-652(4)
Authors: Lupu, Jeremy; Pages, Cécile; Laly, Pauline; Delyon, Julie; Laloi, Marie; Petit, Antoine; Basset-Seguin, Nicole; Oueslati, Imen; Zagdanski, Anne-Marie; Young, Jacques; Bouche, Clara; Lebbé, Céleste; Gautier, Jean-François